The anti-apoptotic activity of albumin for endothelium is inhibited by advanced glycation and products restricting intramolecular movement

• Autorzy: Zoellner H , Siddiqui S. , Kelly E. , Medbury H.
• Języki publikacji: EN

Abstrakty

EN

Human serum albumin (HSA) inhibits endothelial apoptosis in a highly specific manner. CNBr fragmentation greatly increases the effectiveness of this activity, suggesting that this type of protection is mediated by a partially cryptic albumin domain which is transiently exposed by intramolecular movement. Advanced glycation end-product (AGE) formation in HSA greatly reduces its intra-molecular movement. This study aimed to determine if this inhibits the anti-apoptotic activity of HSA, and if such inactivation could be reversed by CNBr fragmentation. HSA-AGE was prepared by incubating HSA with glucose, and assessed using the fructosamine assay, mass spectrometry, SDS-PAGE and fluorometry. Low levels of AGE in the HSA had little effect upon its anti-apoptotic activity, but when the levels of AGE were high and the intra-molecular movement was reduced, endothelial cell survival was also found to be reduced to levels equivalent to those in cultures without HSA or serum (p > 0.001). Survival was restored by the inclusion of native HSA, despite the presence of HSA with high levels of AGE. Also, CNBr fragmentation of otherwise inactive HSA-AGE restored the anti-apoptotic activity for endothelium. Apoptosis was confirmed by DNA gel electrophoresis, transmission electron microscopy and fluorescence-activated cell sorting analysis, and there was no evidence for direct toxicity in the HSA-AGE preparations. The results are consistent with the proposed role of intra-molecular movement in exposing the anti-apoptotic domain in HSA for endothelium. The levels of AGE formation required to inhibit the anti-apoptotic activity of HSA exceeded those reported for diabetes. Nonetheless, the data from this study seems to be the first example of reduced protein function due to AGE-restricted intra-molecular movement.

Słowa kluczowe

EN

anti-apoptotic activity; albumin; endothelium; glycation; intramolecular movement; human serum albumin; human umbilical vein endothelial cell; calf; serum

• Wydawca: -
• Czasopismo: Cellular and Molecular Biology Letters
• Rocznik: 2009
• Tom: 14
• Numer: 4
• Opis fizyczny: p.575-586,fig.,ref.

Twórcy

autor

Zoellner H

• The University of Sydney, Westmead, NSW 2145, Australia

autor

Siddiqui S.

autor

Kelly E.

autor

Medbury H.

Bibliografia

• 1. Araki, S., Shimada, Y., Kaji, K. and Hayashi, H. Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-deprived endothelial cells. Biochem. Biophys. Res. Commun. 172 (1990) 1081- 1085.
• 2. Zoellner, H., Hou, J.Y., Lovery, M., Kingham, J., Srivastava, M., Bielek, E., Vanyek, E. and Binder, B.R. Inhibition of microvascular endothelial apoptosis in tissue explants by serum albumin. Microvasc. Res. 57 (1999) 162-173.
• 3. Zoellner, H., Hofler, M., Beckmann, R., Hufnagl, P., Vanyek, E., Bielek, E., Wojta, J., Fabry, A., Lockie, S. and Binder, B.R. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J. Cell Sci. 109 (1996) 2571-2580.
• 4. Bolitho, C., Bayl, P., Hou, J.Y., Lynch, G., Hassel, A.J., Wall, A.J. and Zoellner, H. The anti-apoptotic activity of albumin for endothelium is mediated by a partially cryptic protein domain and reduced by inhibitors of G-coupled protein and PI-3 kinase, but is independent of radical scavenging or bound lipid. J. Vasc. Res. 44 (2007) 313-324.
• 5. Djousse, L., Rothman, K.J., Cupples, L.A., Levy, D. and Ellison, R.C. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation 106 (2002) 2919-2924.
• 6. Schillinger, M., Exner, M., Mlekusch, W., Amighi, J., Sabeti, S., Schlager, O., Wagner, O. and Minar, E. Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis - interrelation with traditional cardiovascular risk factors. Thromb. Haemost. 91 (2004) 610-618.
• 7. Peters, T. All about albumin - biochemistry, genetics and medical applications. San Diego, Academic Press, 1996.
• 8. Zoellner, H., Hou, J.Y., Hochgrebe, T., Poljak, A., Duncan, M.W., Golding, J., Henderson, T. and Lynch, G. Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin. Biochem. Biophys. Res. Commun. 284 (2001) 83-89.
• 9. Brownlee, M., Vlassara, H. and Cerami, A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Intern. Med. 101 (1984) 527-537.
• 10. John, W.G. and Lamb, E.J. The Maillard or browning reaction in diabetes. Eye 7 ( Pt 2) (1993) 230-237.
• 11. Drickamer, K. Diabetes: Breaking the curse of the AGEs. Nature 382 (1996) 211-212.
• 12. Lee, A.T. and Cerami, A. Role of glycation in aging. Ann. N. Y. Acad. Sci. 663 (1992) 63-70.
• 13. Ahmed, M.U., Thorpe, S.R. and Baynes, J.W. Identification of N epsiloncarboxymethyllysine as a degradation product of fructoselysine in glycated protein. J. Biol. Chem. 261 (1986) 4889-4894.
• 14. Wolff, S.P., Jiang, Z.Y. and Hunt, J.V. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic. Biol. Med. 10 (1991) 339-352.
• 15. Johnson, R.N., Metcalf, P.A. and Baker, J.R. Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin. Chim. Acta 127 (1983) 87-95.
• 16. Emmanuel, C., Foo, E., Medbury, H., Matthews, J., Comis, A. and Zoellner, H. Synergistic induction of apoptosis in human endothelial cells by tumor necrosis factor-α and transforming growth factor-β. Cytokine 18 (2002) 237-241.
• 17. Smith, C.A., Williams, G.T., Kingston, R., Jenkinson, E.J. and Owen, J.J. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T-cells in thymic cultures. Nature 337 (1989) 181-184.
• 18. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M.A., Lassota, P. and Traganos, F. Features of apoptotic cells measured by flow cytometry. Cytometry 13 (1992) 795-808.
• 19. Gerschenson, L.E. and Rotello, R.J. Apoptosis: a different type of cell death. FASEB J. 6 (1992) 2450-2455.
• 20. Raff, M.C., Barres, B.A., Burne, J.F., Coles, H.S., Ishizaki, Y. and Jacobson, M.D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262 (1993) 695-700.
• 21. Kumar, V., Abbas, A.K., Fausto, N. Robbins and Cotran Pathologic Basis of Disease. Philadelphia, W.B. Saunders Co., 2004.
• 22. Zoellner, H., Bielek, E., Vanyek, E., Fabry, A., Wojta, J., Hofler, M. and Binder, B.R. Canalicular fragmentation of apoptotic human endothelial cells. Endothelium 4 (1996) 177-188.
• 23. Xu, W., Boadle, R., Dear, L., Cvejic, M., Emmanuel, C. and Zoellner, H. Ultrastructural changes in endothelium during apoptosis indicate low microembolic potential. J. Vasc. Res. 42 (2005) 377-387.
• 24. Chibber, R., Molinatti, P.A., Rosatto, N., Lambourne, B. and Kohner, E.M. Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy. Diabetologia 40 (1997) 156-164.
• 25. Min, C., Kang, E., Yu, S., Shinn, S. and Kim, Y. Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells. Diabetes Res. Clin. Pract. 46 (1999) 197-202.
• 26. Kowluru, R.A. Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions. Life Sci. 76 (2005) 1051-1060.
• 27. Xiang, M., Yang, M., Zhou, C., Liu, J., Li, W. and Qian, Z. Crocetin prevents AGEs-induced vascular endothelial cell apoptosis. Pharmacol. Res. 54 (2006) 268-274.
• 28. Stefani, M. Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim. Biophys. Acta 1739 (2004) 5-25.
• 29. Cantara, S., Ziche, M. and Donnini, S. Opposite effects of beta amyloid on endothelial cell survival: role of fibroblast growth factor-2 (FGF-2). Pharmacol. Rep. 57 Suppl (2005) 138-143.
• 30. Cecchi, C., Pensalfini, A., Baglioni, S., Fiorillo, C., Caporale, R., Formigli, L., Liguri, G. and Stefani, M. Differing molecular mechanisms appear to underlie early toxicity of prefibrillar HypF-N aggregates to different cell types. FEBS J. 273 (2006) 2206-2222.
• 31. Bouma, B., Kroon-Batenburg, L.M., Wu, Y.P., Brunjes, B., Posthuma, G., Kranenburg, O., de Groot, P.G., Voest, E.E. and Gebbink, M.F. Glycation induces formation of amyloid cross-beta structure in albumin. J. Biol. Chem. 278 (2003) 41810-41819.
• 32. Rondeau, P., Singh, N.R., Caillens, H., Tallet, F., and Bourdon, E. Oxidative stress induced by glycoxidized human or bovine serum albumin on human monocytes. Free Radic. Biol. Med. 45 (2008) 799-812.
• 33. Hunt, J.V., Bottoms, M.A., and Mitchinson, M.J. Oxidative alterations in experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production. Biochem. J. 291 (1993) 529-535.
• 34. Darby, I.A., Bisucci, T., Hewitson, T.D. and MacLellan, D.G. Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice. Int. J. Biochem. Cell Biol. 29 (1997) 191-200.
• 35. Mizutani, M., Kern, T.S. and Lorenzi, M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J. Clin. Invest. 97 (1996) 2883-2890.
• 36. Thornalley, P.J., Argirova, M., Ahmed, N., Mann, V.M., Argirov, O. and Dawnay, A. Mass spectrometric monitoring of albumin in uremia. Kidney Int. 58 (2000) 2228-2234.